Krahasoni metodat

	Studim i Përputhur i Saktësisë Diagnostike	Studim Epidemiologjik Kryq-Seksional
Fusha	Epidemiologji	Epidemiologji
Familja	Process / pipeline	Process / pipeline
Viti i origjinës	1990s–2000s (formalised with STARD 2003)	1960s (formal codification); widely practiced since mid-20th century
Krijuesi	Evolved from matched case-control methodology; STARD standards formalised by Bossuyt et al. (2003)	Classical epidemiology tradition; systematized by Brian MacMahon and Thomas Pugh (1960s)
Lloji	Diagnostic / clinical epidemiology study design	Observational, descriptive/analytic epidemiological design
Burimi themelues	Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., & de Vet, H. C. W. (2003). Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative. BMJ, 326(7379), 41–44.	Kelsey, J. L., Whittemore, A. S., Evans, A. S., & Thompson, W. D. (1996). Methods in Observational Epidemiology (2nd ed.). Oxford University Press. ISBN: 978-0195080407
Emërtime të tjera	matched DAS, paired diagnostic accuracy study, matched test accuracy study, matched sensitivity-specificity study	prevalence study, cross-sectional survey, transversal study, cross-sectional design
Të lidhura	4	6
Përmbledhja	A matched diagnostic accuracy study evaluates how well an index test correctly identifies a target condition in study participants who have been matched on key characteristics — such as age, sex, or disease severity — to control for confounding. By pairing diseased and non-diseased subjects on relevant factors before administering the test, the design isolates the test's own discriminative performance from variation attributable to imbalanced covariates, yielding cleaner estimates of sensitivity, specificity, and related accuracy measures.	A cross-sectional epidemiological study measures the exposure(s) and outcome(s) of interest simultaneously in a defined population at a single point in time (or over a short period). Because there is no follow-up, it is the most efficient observational design for estimating disease prevalence and for generating hypotheses about associations between risk factors and health outcomes.